Is red wine the next breakthrough therapy in the world of drug-eluting stents and balloons? The research looks promising, according to Dr. John Foley, cofounder of Requisite Biomedical. Requisite Biomedical was founded in 2009 to develop intravascular medical device coatings containing a combination of the natural compounds found in red wine – resveratrol and quercetin. […]
When we last checked in with ReQuisite Biomedical, the Minnesota startup that’s developing a novel coating for stents and balloons was plotting a move to Ohio. More than a year later, the move is still squarely in the planning stages, co-founder John Foley said. But recently released promising preclinical data has Foley hoping that ReQuisite […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Armed with a $100,000 grant from Lorain County Community College's Innovation Fund, ReQuisite Biomedical would like to raise another $800,000 before relocating, said co-founder and Chief Executive John Foley.
Case Western Reserve University and University Hospitals Case Medical Center will participate in a consortium of national experts investigating why unexplained anemia is common in older adults. The consortium, called the Partnership for Anemia: Clinical and Translational Trials in the Elderly, is the result of a $16 million grant awarded by the National Institute on Aging.